TABLE 1.
Cancer-specific patient characteristics stratified by surgery type*
| Variable | ORP | RALP | P† |
|---|---|---|---|
| At diagnosis | |||
| Mean (SD): | |||
| Age, years | 59.2 (6.66) | 59.7 (7.11) | 0.23 |
| PSA level, ng/mL | 7.6 (7.26) | 7.1 (5.39) | 0.33 |
| Prostate volume, mL | 34.3 (19.55) | 34.5 (18.34) | 0.91 |
| N (%): | |||
| Race/ethnicity: | 0.36 | ||
| Caucasian | 602 (92) | 254 (90) | |
| Other | 55 (8) | 29 (10) | |
| Biopsy Gleason grade: | 0.24 | ||
| 6 (3 + 3) | 354 (53) | 166 (58) | |
| 7 (3 + 4) | 149 (23) | 70 (24) | |
| 7 (4 + 3) | 84 (13) | 29 (10) | |
| 8–10 | 75 (11) | 23 (8) | |
| cT-Stage: | <0.01 | ||
| T1 | 242 (36) | 159 (56) | |
| T2 | 434 (64) | 123 (44) | |
| T3 | 4 (1) | 0 | |
| Clinical risk group: | 0.05 | ||
| Low | 224 (35) | 120 (43) | |
| Intermediate | 251 (39) | 101 (36) | |
| High | 163 (26) | 56 (20) | |
| Surgery and pathology | |||
| N (%): | |||
| Transfusion: | <0.01 | ||
| No | 641 (92) | 291 (100) | |
| Yes | 54 (8) | 1 (<1) | |
| Positive margins: | 0.25 | ||
| No | 587 (84) | 238 (82) | |
| Yes | 108 (16) | 54 (18) | |
| pT-Stage: | <0.01 | ||
| T2 | 478 (69) | 242 (83) | |
| T3 | 214 (31) | 49 (17) | |
| pN-Stage: | <0.01 | ||
| NX | 380 (55) | 231 (79) | |
| N0 | 289 (41) | 61 (21) | |
| N1 | 26 (4) | 0 | |
| Gleason grade | 0.29 | ||
| 2–6 | 220 (32) | 103 (36) | |
| 7–10 | 464 (68) | 186 (64) | |
| Neo-adjuvant radiation: | 0.26 | ||
| No | 692 (100) | 292 (100) | |
| Yes | 3 (<1) | 0 | |
| Adjuvant radiation: | 0.16 | ||
| No | 675 (97) | 288 (99) | |
| Yes | 20 (3) | 4 (1) | |
*
Categories may not total to ‘n’ due to missing values;
†
chi-squared.